Table 1.
Age (wks)1 |
|||||||
---|---|---|---|---|---|---|---|
1 | 2 | 4 | 8 | 20 | 32 | ||
IGF-I (ng/mL) | |||||||
male | mean±SD | 53± 8 | 158±30 | 594±84 | 636±48 | 522±37 | 395±64 |
median | 56 | 158 | 580 | 638 | 512 | 398 | |
range | 42–63 | 123–192 | 475–694 | 550–692 | 483–589 | 315–517 | |
female | mean±SD | 102±21 | 211±66 | 548±77 | 417±61 | 539±78 | 535±88 |
median | 93 | 200 | 542 | 414 | 541 | 522 | |
range | 87–126 | 156–288 | 418–666 | 348–537 | 389–655 | 396–664 | |
IGFBP-3 (ng/mL) | |||||||
male | mean±SD | 1213±173 | 2267±164 | 2800±428 | 2248±338 | 1808±314 | 1102±168 |
median | 1245 | 2231 | 2707 | 2208 | 1673 | 1070 | |
range | 946–1508 | 2048–2614 | 2205–3519 | 1781–2925 | 1407–2239 | 871–1352 | |
female | mean±SD | 1078±108 | 2643±232 | 2699±398 | 1925±439 | 1776±522 | 1653±337 |
median | 1097 | 2531 | 2672 | 1827 | 1687 | 1638 | |
range | 867–1217 | 2444–3166 | 1998–3441 | 1469–2965 | 1212–3055 | 1108–3296 | |
ALS (ng/mL) | |||||||
male | mean±SD | 1052±237 | 2090±201 | 4721±281 | 5371±785 | 4484±385 | 3599±483 |
median | 1001 | 2026 | 4654 | 5328 | 4408 | 3490 | |
range | 731–1534 | 1858–2433 | 4443–5263 | 4469–6626 | 4004–5075 | 2910–4521 | |
female | mean±SD | 1238±268 | 2360±738 | 4860±547 | 3741±910 | 4107±808 | 4121±638 |
median | 1167 | 2199 | 4673 | 3596 | 4140 | 4074 | |
range | 905–1753 | 1481–3826 | 4520–5934 | 2632–4738 | 2813–5132 | 3328–5225 | |
IGF-1 to IGFBP-3 molar ratio (%) | |||||||
male | mean±SD | 23±8 | 44±12 | 80±7 | 105±16 | 112±18 | 141±28 |
median | 22 | 42 | 80 | 107 | 115 | 143 | |
range | 16–40 | 27–59 | 71–94 | 85–128 | 84–135 | 105–182 | |
female | mean±SD | 36±3 | 52±10 | 79±8 | 91±10 | 122±22 | 131±44 |
median | 35 | 49 | 80 | 90 | 124 | 122 | |
range | 33–40 | 44–66 | 64–91 | 78–109 | 83–156 | 93–232 | |
IGFBP-3 to ALS molar ratio (%)2 | |||||||
male | 270 | 254 | 139 | 98 | 95 | 72 | |
female | 204 | 262 | 130 | 120 | 101 | 94 | |
IGF-I to ALS molar ratio (%)2 | |||||||
male | 46 | 69 | 114 | 107 | 106 | 100 | |
female | 75 | 81 | 102 | 101 | 119 | 118 |
n=6–8 for each sex at each age
ALS levels were from a different population. Therefore, the IGFBP-3 and IGF-I to ALS molar ratios are estimated from the mean levels for each age and sex.